ATE278700T1 - Anthracyclin prodrugs, verfahren zu deren herstellung und deren verwendung in der selektiven chemotherapie - Google Patents

Anthracyclin prodrugs, verfahren zu deren herstellung und deren verwendung in der selektiven chemotherapie

Info

Publication number
ATE278700T1
ATE278700T1 AT95201747T AT95201747T ATE278700T1 AT E278700 T1 ATE278700 T1 AT E278700T1 AT 95201747 T AT95201747 T AT 95201747T AT 95201747 T AT95201747 T AT 95201747T AT E278700 T1 ATE278700 T1 AT E278700T1
Authority
AT
Austria
Prior art keywords
production
derivatives
anthracycline
selective chemotherapy
disclosed
Prior art date
Application number
AT95201747T
Other languages
English (en)
Inventor
Ruben Gerardus George Leenders
Eric Wilhelmus Petrus Damen
Johan Wilhelm Scheeren
Hidde Jacob Haisma
Pieter Herman Johannes Houba
Vos Dick De
Original Assignee
Pharmachemie Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmachemie Bv filed Critical Pharmachemie Bv
Application granted granted Critical
Publication of ATE278700T1 publication Critical patent/ATE278700T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT95201747T 1995-06-27 1995-06-27 Anthracyclin prodrugs, verfahren zu deren herstellung und deren verwendung in der selektiven chemotherapie ATE278700T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95201747A EP0751144B1 (de) 1995-06-27 1995-06-27 Anthracyclin Prodrugs, Verfahren zu deren Herstellung und deren Verwendung in der selektiven Chemotherapie

Publications (1)

Publication Number Publication Date
ATE278700T1 true ATE278700T1 (de) 2004-10-15

Family

ID=8220425

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95201747T ATE278700T1 (de) 1995-06-27 1995-06-27 Anthracyclin prodrugs, verfahren zu deren herstellung und deren verwendung in der selektiven chemotherapie

Country Status (9)

Country Link
US (1) US5710135A (de)
EP (1) EP0751144B1 (de)
JP (1) JPH0912591A (de)
AT (1) ATE278700T1 (de)
CA (1) CA2178684A1 (de)
DE (1) DE69533615T2 (de)
DK (1) DK0751144T3 (de)
ES (1) ES2227536T3 (de)
PT (1) PT751144E (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19720312A1 (de) * 1997-05-15 1998-11-19 Hoechst Ag Zubereitung mit erhöhter in vivo Verträglichkeit
US6180095B1 (en) 1997-12-17 2001-01-30 Enzon, Inc. Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents
WO1999030727A1 (en) 1997-12-17 1999-06-24 Enzon, Inc. Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents
US6624142B2 (en) 1997-12-30 2003-09-23 Enzon, Inc. Trimethyl lock based tetrapartate prodrugs
US5965119A (en) * 1997-12-30 1999-10-12 Enzon, Inc. Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
US6214330B1 (en) 1998-07-13 2001-04-10 Enzon, Inc. Coumarin and related aromatic-based polymeric prodrugs
US6043367A (en) * 1998-09-30 2000-03-28 Roffler; Steve Proactive antitumor compounds
EP1343494A4 (de) * 2000-12-01 2005-08-03 Enzon Inc Tetrapartat-prodrugs
AU2002251988A1 (en) * 2001-02-20 2002-09-04 Enzon, Inc. Terminally-branched polymeric linkers and polymeric conjugates containing the same
AU2002320964B2 (en) * 2001-08-14 2008-03-13 Valderm Aps Treatment of hyperproliferative conditions of body surfaces
US20040038904A1 (en) * 2002-05-21 2004-02-26 Angela Ogden Method of treating multiple sclerosis
EP2357009A1 (de) 2002-07-15 2011-08-17 Board of Regents, The University of Texas System Duramycin-peptid mit bindung an anionische Phospholipide und Aminophospholipide Konjugate und ihre Verwendung bei der Behandlung von Virusinfektionen
ES2572356T3 (es) 2007-11-09 2016-05-31 Peregrine Pharmaceuticals Inc Composiciones de anticuerpos dirigidos contra VEGF y procedimientos
EP2098533A1 (de) * 2008-03-07 2009-09-09 Pharmachemie B.V. Ester aus Glucuronid-Prodrugs von Anthracyclinen und Verfahren zu deren Herstellung und Verwendung bei der tumorselektiven Chemotherapie
EP2538929A4 (de) 2010-02-25 2014-07-09 Univ Johns Hopkins Verzögerte freisetzung von therapiemitteln in einen teil des auges
US10307372B2 (en) 2010-09-10 2019-06-04 The Johns Hopkins University Rapid diffusion of large polymeric nanoparticles in the mammalian brain
WO2012109363A2 (en) 2011-02-08 2012-08-16 The Johns Hopkins University Mucus penetrating gene carriers
CA2863632C (en) 2012-01-19 2017-07-11 The Johns Hopkins University Nanoparticle formulations with enhanced mucosal penetration
JP6138904B2 (ja) 2012-03-16 2017-05-31 ザ・ジョンズ・ホプキンス・ユニバーシティー 活性剤の送達のための非線状マルチブロックコポリマー薬物コンジュゲート
US8962577B2 (en) 2012-03-16 2015-02-24 The Johns Hopkins University Controlled release formulations for the delivery of HIF-1 inhibitors
AU2013256008B2 (en) 2012-05-04 2016-02-25 The Johns Hopkins University Lipid-based drug carriers for rapid penetration through mucus linings
US9533068B2 (en) 2012-05-04 2017-01-03 The Johns Hopkins University Drug loaded microfiber sutures for ophthalmic application
CN103910875B (zh) * 2012-12-31 2017-06-13 张雅珍 蒽环类抗生素偶联非线性多嵌段共聚物及其制备方法和应用
WO2014124006A1 (en) 2013-02-05 2014-08-14 The Johns Hopkins University Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof
WO2015127368A1 (en) 2014-02-23 2015-08-27 The Johns Hopkins University Hypotonic microbicidal formulations and methods of use
CN107635545A (zh) 2015-01-27 2018-01-26 约翰霍普金斯大学 用于增强粘膜表面处活性剂的输送的低渗水凝胶制剂
US12496279B2 (en) 2019-04-11 2025-12-16 The Johns Hopkins University Nanoparticles for drug delivery to brain

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0048041A3 (en) * 1978-03-27 1982-08-04 Discovision Associates Method and apparatus for writing a signal-information track by using a radiation beam
DE4002888A1 (de) 1990-02-01 1991-08-08 Behringwerke Ag Anthracyclin-glycosyl-prodrugs, verfahren zu ihrer herstellung und ihre verwendung in kombination mit funktionalisierten tumorspezifischen enzymkonjugaten
FR2676058B1 (fr) 1991-04-30 1994-02-25 Hoechst Lab Prodrogues glycosylees, leur procede de preparation et leur utilisation dans le traitement des cancers.
DE4236237A1 (de) 1992-10-27 1994-04-28 Behringwerke Ag Prodrugs, ihre Herstellung und Verwendung als Arzneimittel

Also Published As

Publication number Publication date
DE69533615D1 (de) 2004-11-11
JPH0912591A (ja) 1997-01-14
EP0751144A1 (de) 1997-01-02
ES2227536T3 (es) 2005-04-01
PT751144E (pt) 2004-12-31
DK0751144T3 (da) 2004-12-27
US5710135A (en) 1998-01-20
CA2178684A1 (en) 1996-12-28
DE69533615T2 (de) 2005-10-13
EP0751144B1 (de) 2004-10-06

Similar Documents

Publication Publication Date Title
ATE278700T1 (de) Anthracyclin prodrugs, verfahren zu deren herstellung und deren verwendung in der selektiven chemotherapie
WO2000006771A3 (en) Nucleic acid labeling compounds
ATE216394T1 (de) Paclitaxel prodrogen, verfahren zur herstellung und ihre verwendung zur selektiven chemotherapie
DE69421569D1 (de) Nichtreduzierende Oligosaccharide und ihre Herstellung und Verwendung
ATE414094T1 (de) Zuckerverbindungen
ATE319481T1 (de) Modifizierte saccharide, deren konjugate sowie deren herstellung
ATE234304T1 (de) Zwischenprodukte zur herstellung von duocarmycin sa und dessen derivaten sowie ein verfahren zur herstellung der zwischenprodukte
WO2002072779A3 (en) Nucleic acid labeling compounds
KR970043038A (ko) 스트렙토마이세스엑스포리아투스(streptomycesexfoliatus)yj-118과이를이용한프라바스타틴나트륨의제조방법
DK1255747T3 (da) Syntese af 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-on
DK1127886T3 (da) Syntese af 3,6-dialkyl-5,6-dihydro-4-hydroxy-2H-pyran-2-on
WO2008090829A1 (ja) リボ核酸化合物の製造方法
DE69020645D1 (de) Antitumor- und Antibiotikum-Substanz, ihre Herstellung und Verwendungen.
ATE115558T1 (de) Harnstoffderivate, deren herstellung sowie diese enthaltende pharmazeutische zusammensetzungen.
DE3888066D1 (de) Saccharid-Derivate.
AU1554592A (en) Interleukin 6 composition and production thereof
EP1325928A4 (de) Verfahren zur herstellung von pregnanderivaten
EA200800653A1 (ru) Способ получения сахарозы-6-ацетата путем цельноклеточного биокатализа
SE7703770L (sv) Sett att framstella nya aminosockerderivat och anvendning derav som lekemedel
ATE243707T1 (de) Organische festphasensynthese
EP1471068A4 (de) Verfahren zur totalsynthese von ecteinascidinen und zwischenprodukte dafür
TR200101279T2 (tr) Vankoremisin, üretimi için işlem ve farmatik olarak kullanımı
RU2001116104A (ru) Ванкорезмицин, способ его получения и его использование в качестве лекарственного средства
NO810778L (no) Homositronsyre oligoriboside-derivater, fremgangsmaate for deres fremstilling og deres bruk for aa forebygge dental karries
WO2021205155A3 (en) C5-modified-3'-aminooxy thymidine derivatives and their use in de novo nucleic acid synthesis

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0751144

Country of ref document: EP

REN Ceased due to non-payment of the annual fee